Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

The Cooper Companies, Inc. COO

Healthcare  —  Medical Instruments & Supplies
55.38 0.00 0.00% as of 25 Sep
Market cap
$10.5B
P/E
18.9×
S&P 500 Member Dividend Champion (10y) Revenue Champion (5y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

The Cooper Companies, Inc. (COO) Price to free cash flow

As of 25 September 2026, The Cooper Companies, Inc. (COO) trades at a price to free cash flow of 15.8×. Over the past ten years it has ranged from 15.2× (September 2026) to 159× (May 2024); the current reading is higher than 0% of that period. That is below the Medical Instruments & Supplies industry median of 25.7× and below the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 32.1× (55.59%)
FY2024 72.3× 0.74%
FY2023 71.7× 139.49%
FY2022 30.0× (24.36%)
FY2021 39.6× (55.66%)
FY2020 89.3× 161.64%
FY2019 34.1× 27.93%
FY2018 26.7× 5.93%
FY2017 25.2× 5.34%
FY2016 23.9× (52.87%)

Quarterly

Period Price to free cash flow Change
Jul 2026 20.6× (4.41%)
Apr 2026 21.5× (33.01%)
Jan 2026 32.1× 0.17%
Oct 2025 32.1× (6.17%)
43 more quarters

Against its own ten years

Low 15.2× High 159×
Ten-year median 37.3×
Current reading's percentile 0

Price to free cash flow against peers

Company Price to free cash flow
STVN Stevanato Group S.p.A. compare n/m
SOLV Solventum Corporation compare n/m
BAX Baxter International Inc. compare 14.8×
ALGN Align Technology, Inc. compare 15.5×
COO The Cooper Companies, Inc. 15.8×
AVTR Avantor, Inc. compare 22.7×
ATR AptarGroup, Inc. compare 25.1×
BLCO Bausch + Lomb Corporation compare 53.9×
RGEN Repligen Corporation compare 175×
Medical Instruments & Supplies industry median 25.7×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on COO